An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment
NCT00737009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 259
Last updated 2011-06-22
Summary
The purpose of this study is to describe adherence to anastrozole treatment current practice: cases where anastrozole treatment was halted ( timescale and causes) and estimate the proportion of postmenopausal women with early breast cancer who continue anastrozole therapy after one year follow-up.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Nguyen Van Dinh, MD · K Hospital Hanoi, Vietnam
-
Tran Nguyen Ha · HCMC Cancer Hospital
-
Tran Dang Khoa · Hanoi Cancer Hospital
-
Ton That Cau · Hue Central Hospital
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2011-03-31
- Completion
- 2011-03-31
Countries
- Vietnam
Study Locations
More Related Trials
-
Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer
NCT00301457 ·Status: COMPLETED ·Phase: PHASE3
-
Anastrozole and Letrozole
NCT00762294 ·Status: COMPLETED
-
3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer
NCT00300508 ·Status: COMPLETED ·Phase: PHASE3
-
Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
NCT00542594 ·Status: TERMINATED
-
Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence
NCT01081509 ·Status: COMPLETED
-
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
NCT00078832 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer
NCT03186599 ·Status: UNKNOWN ·Phase: NA
-
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
NCT00248170 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
NCT00332852 ·Status: COMPLETED ·Phase: PHASE3
-
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
NCT00516698 ·Status: COMPLETED
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors
NCT03144037 ·Status: COMPLETED
-
Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
NCT00357110 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women
NCT00256217 ·Status: COMPLETED ·Phase: PHASE2
-
APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)
NCT00523315 ·Status: COMPLETED
-
Liver Safety Under Upfront Arimidex vs Tamoxifen
NCT00537771 ·Status: COMPLETED ·Phase: PHASE4
-
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
NCT04272801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.
NCT00291759 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in HR+ Breast Cancer Patients
NCT02812277 ·Status: UNKNOWN
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00090857 ·Status: COMPLETED ·Phase: PHASE2
-
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)
NCT00126360 ·Status: UNKNOWN ·Phase: PHASE4
-
Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene
NCT01072318 ·Status: UNKNOWN ·Phase: PHASE4
-
Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer
NCT02506361 ·Status: RECRUITING
-
CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)
NCT00681122 ·Status: COMPLETED